연구동향 분석

Inhaled Colistin for Treatment of Pneumonia due to Colistin-Only-Susceptible Acinetobacter baumannii

최희경 어영 김영근 김효열 2014년

논문상세정보
인용/피인용
' Inhaled Colistin for Treatment of Pneumonia due to Colistin-Only-Susceptible Acinetobacter baumannii' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • acinetobacter baumannii
  • colistin
  • pneumonia
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,810 0

0.0%

' Inhaled Colistin for Treatment of Pneumonia due to Colistin-Only-Susceptible Acinetobacter baumannii' 의 참고문헌

  • Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment?
    Kalin G J Infect Chemother 18 872-877 [2012]
  • Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin
    Hamer DH Am J Respir Crit Care Med 162 328-330 [2000]
  • Treatment of Acinetobacter spp infections
    Levin AS Expert Opin Pharmacother 4 1289-1296 [2003]
  • Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline
    Taccone FS Eur J Clin Microbiol Infect Dis 25 257-260 [2006]
  • Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration
    Imberti R Chest 138 1333-1339 [2010]
  • Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin
    Rodriguez CH Diagn Microbiol Infect Dis 65 188-191 [2009]
  • Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant Gram-negative bacilli with inhaled polymyxin B
    Pereira GH Diagn Microbiol Infect Dis 58 235-240 [2007]
  • Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii with aerosolized colistin in neonates: a preliminary report
    Nakwan N Pediatr Pulmonol 46 60-66 [2011]
  • Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study
    Matthaiou DK Crit Care Med 36 807-811 [2008]
  • Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system
    Adams MD Antimicrob Agents Chemother 53 3628-3634 [2009]
  • Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria
    Rattanaumpawan P J Antimicrob Chemother 65 2645-2649 [2010]
  • Pseudomonas aeruginosa susceptible only to colistin in intensive care unit patients
    Mastoraki A Surg Infect (Larchmt) 9 153-160 [2008]
  • Pharmacokinetics of inhaled colistin in patients with cystic fibrosis
    Ratjen F J Antimicrob Chemother 57 306-311 [2006]
  • Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review
    Celik IH Eur J Pediatr 171 311-316 [2012]
  • Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center
    Hartzell JD Clin Infect Dis 48 1724-1728 [2009]
  • Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa
    Lu Q Am J Respir Crit Care Med 184 106-115 [2011]
  • Inhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis
    Falagas ME Pediatr Pulmonol 45 1135-1140 [2010]
  • Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series
    Falagas ME Respir Med 103 707-713 [2009]
  • Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study
    Korbila IP Clin Microbiol Infect 16 1230-1236 [2010]
  • Inhaled anti-infective agents: emphasis on colistin
    Michalopoulos A Infection 38 81-88 [2010]
  • In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates
    Owen RJ J Antimicrob Chemother 59 473-477 [2007]
  • Imipenem 내성 Acinetobacter baumannii에서 항균제 병합요법의 시험관내 상승작용 검사
    성흥섭 Annals of Laboratory Medicine 27 2 111-117 [2007]
  • High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea
    Ko KS JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 60 5 1163-1167 [2007]
  • Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii
    Li J Antimicrob Agents Chemother 50 2946-2950 [2006]
  • Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria
    Falagas ME Eur J Clin Microbiol Infect Dis 25 596-599 [2006]
  • Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines
    Gales AC J Clin Microbiol 39 183-190 [2001]
  • Comparative evaluation of the sensitivity of Acinetobacter to colistin, using the prediffusion and minimum inhibitory concentration methods: detection of heteroresistant isolates
    Herrera ME Rev Argent Microbiol 43 115-119 [2011]
  • Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme
    Yau W J Infect 58 138-144 [2009]
  • Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii
    Motaouakkil S J Infect 53 274-278 [2006]
  • CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting
    Horan TC Am J Infect Control 36 309-332 [2008]
  • Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study
    Kofteridis DP Clin Infect Dis 51 1238-1244 [2010]
  • Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis
    Michalopoulos A Crit Care 9 R53-R59 [2005]
  • Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan
    Lin CC J Microbiol Immunol Infect 43 323-331 [2010]
  • Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study
    Michalopoulos A Respir Med 102 407-412 [2008]
  • Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit
    Palmer LB Crit Care Med 36 2008-2013 [2008]
  • A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa
    Naesens R BMC Infect Dis 11 317- [2011]